Social Pulse: Ligand Pharmaceuticals Inc (LGND.OQ)
LGND.OQ on NASDAQ Stock Exchange Global Market
49.02USD
1 Aug 2013
49.02USD
1 Aug 2013
Price Change (% chg)
$1.64 (+3.46%)
$1.64 (+3.46%)
Prev Close
$47.38
$47.38
Open
$48.04
$48.04
Day's High
$50.39
$50.39
Day's Low
$46.85
$46.85
Volume
62,857
62,857
Avg. Vol
77,473
77,473
52-wk High
$50.77
$50.77
52-wk Low
$14.77
$14.77
- Ligand Pharmaceuticals Incorporated Management Discusses Q2 2013 Results - Earnings Call Transcript
- Why Cytokinetics Is Poised to Pull Back
- FDA Decisions: Interesting Biotechnology Catalyst Events
- 4 Stocks Spiking on Big Volume
- Clinical Trial Disappointment for This Pharmaceutical Giant
- Ligand Pharmaceuticals Incorporated Management Discusses Q1 2013 Results - Earnings Call Transcript
Press Releases
- U.S. Food and Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention of Osteoporosis
- U.S. Food And Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention Of Osteoporosis
- Ligand Initiates Pivotal Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan in Patients with Multiple Myeloma
- Ligand to Present Growth Prospects, Review Key Portfolio Assets and Introduce Financial Guidance at Analyst Day Event
- Reminder: Ligand to Host Analyst Day on December 4th in New York City

